Chicago Capital Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Chicago Capital Management's BSX.PRA Position: Q2 2023 in Review
Chicago Capital Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 4,312 shares — an estimated $522K sold.
Chicago Capital Management first reported a position in BSX.PRA in Q3 2022 and held it in 3 quarters. The position peaked at $655K in Q4 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- Chicago Capital Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- Chicago Capital Management sold 4,312 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $522K.
- Chicago Capital Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q3 2022 and held it in 3 quarters.
- Chicago Capital Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $655K in Q4 2022.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on Chicago Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.